A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates
Monocarboxylate transporter 1 (MCT1) is responsible for oral absorption of short-chain monocarboxylic acids from small intestine, hence, it's likely to serve as an ideal design target for the development of oral prodrugs. However, potential application of MCT1 to facilitate the oral delivery is...
Saved in:
Main Authors: | Yixin Sun (Author), Dongyang Zhao (Author), Gang Wang (Author), Qikun Jiang (Author), Mengran Guo (Author), Qiming Kan (Author), Zhonggui He (Author), Jin Sun (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability
by: Gang Wang, et al.
Published: (2020) -
Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
by: Jincheng Yang, et al.
Published: (2018) -
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine-Feasibility of Orally Administrable Nucleoside Analogs
by: Yasuhiro Tsume, et al.
Published: (2014) -
Regulation of the exercise-induced expression of the monocarboxylate transporters MCT1 and MCT4 in skeletal muscle
by: Taku Hamada, et al.
Published: (2013) -
Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development
by: Yixin Sun, et al.
Published: (2020)